Zeidan Esraa M, Hossain Mohammad Akbar, El-Daly Mahmoud, Abourehab Mohammed A S, Khalifa Mohamed M A, Taye Ashraf
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Department of Pharmacology and Toxicology, Faculty of Medicine at Al Qunfudah, Umm Al Qura University, Al Qunfudah 77207, Saudi Arabia.
J Clin Med. 2022 Sep 3;11(17):5219. doi: 10.3390/jcm11175219.
Pulmonary hypertension (PH) is a severe progressive lung disorder characterized by pulmonary vasoconstriction and vascular remodeling, culminating in right-sided heart failure and increased mortality. Data from animal models and human subjects demonstrated that hypoxia-inducible factor (HIF)-related signaling is essential in the progression of PH. This review summarizes the regulatory pathways and mechanisms of HIF-mediated signaling, emphasizing the role of mitochondria in HIF regulation and PH pathogenesis. We also try to determine the potential to therapeutically target the components of the HIF system for the management of PH.
肺动脉高压(PH)是一种严重的进行性肺部疾病,其特征为肺血管收缩和血管重塑,最终导致右心衰竭并增加死亡率。来自动物模型和人类受试者的数据表明,缺氧诱导因子(HIF)相关信号在PH的进展中至关重要。本综述总结了HIF介导信号的调控途径和机制,强调了线粒体在HIF调控和PH发病机制中的作用。我们还试图确定靶向HIF系统成分进行PH治疗的潜力。